ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 109 filers reported holding ANI PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 1.01 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $77,000 | +18.5% | 2,401 | +9.1% | 0.00% | 0.0% |
| Q2 2022 | $65,000 | +25.0% | 2,200 | +20.0% | 0.00% | 0.0% |
| Q1 2022 | $52,000 | -23.5% | 1,833 | +23.9% | 0.00% | 0.0% |
| Q4 2021 | $68,000 | +61.9% | 1,479 | +14.5% | 0.00% | – |
| Q3 2021 | $42,000 | -14.3% | 1,292 | -8.4% | 0.00% | – |
| Q2 2021 | $49,000 | +6.5% | 1,411 | +9.7% | 0.00% | – |
| Q1 2021 | $46,000 | +31.4% | 1,286 | +7.3% | 0.00% | – |
| Q4 2020 | $35,000 | +9.4% | 1,199 | +4.2% | 0.00% | – |
| Q3 2020 | $32,000 | +113.3% | 1,151 | +150.2% | 0.00% | – |
| Q2 2020 | $15,000 | -11.8% | 460 | +13.0% | 0.00% | – |
| Q1 2020 | $17,000 | -19.0% | 407 | +22.2% | 0.00% | – |
| Q4 2019 | $21,000 | -16.0% | 333 | -3.2% | 0.00% | – |
| Q3 2019 | $25,000 | 0.0% | 344 | +14.7% | 0.00% | – |
| Q2 2019 | $25,000 | +47.1% | 300 | +26.6% | 0.00% | – |
| Q1 2019 | $17,000 | +88.9% | 237 | +13.9% | 0.00% | – |
| Q4 2018 | $9,000 | 0.0% | 208 | +32.5% | 0.00% | – |
| Q3 2018 | $9,000 | +350.0% | 157 | +375.8% | 0.00% | – |
| Q2 2018 | $2,000 | -99.9% | 33 | -99.9% | 0.00% | -100.0% |
| Q3 2016 | $1,989,000 | +18.9% | 29,978 | 0.0% | 0.04% | +11.1% |
| Q2 2016 | $1,673,000 | +65.8% | 29,978 | 0.0% | 0.04% | +63.6% |
| Q1 2016 | $1,009,000 | -25.9% | 29,978 | -0.7% | 0.02% | -29.0% |
| Q4 2015 | $1,362,000 | +14.9% | 30,178 | +0.6% | 0.03% | +10.7% |
| Q3 2015 | $1,185,000 | -13.2% | 30,000 | +36.4% | 0.03% | -6.7% |
| Q2 2015 | $1,365,000 | -11.9% | 22,000 | -11.1% | 0.03% | -11.8% |
| Q1 2015 | $1,549,000 | -71.0% | 24,760 | -73.8% | 0.03% | -71.7% |
| Q4 2014 | $5,336,000 | +211.0% | 94,628 | +72.9% | 0.12% | +192.7% |
| Q1 2014 | $1,716,000 | -15.0% | 54,737 | -45.6% | 0.04% | -16.3% |
| Q4 2013 | $2,019,000 | +2303.6% | 100,557 | +1071.6% | 0.05% | +2350.0% |
| Q3 2013 | $84,000 | – | 8,583 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FIRST WILSHIRE SECURITIES MANAGEMENT INC | 367,754 | $10,911,000 | 4.08% |
| AIGH Capital Management LLC | 244,500 | $7,254,000 | 1.91% |
| Parkman Healthcare Partners LLC | 108,559 | $3,221,000 | 1.19% |
| Worth Venture Partners, LLC | 60,831 | $1,927,000 | 1.13% |
| Global Alpha Capital Management Ltd. | 323,731 | $9,605,000 | 1.04% |
| Mesirow Financial Investment Management, Inc. | 6,892 | $204,000 | 0.99% |
| MARATHON CAPITAL MANAGEMENT | 74,460 | $2,209,000 | 0.71% |
| EMERALD ADVISERS, LLC | 455,880 | $13,526,000 | 0.70% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 356,865 | $10,588,000 | 0.61% |
| Jackson Creek Investment Advisors LLC | 32,698 | $1,120,000 | 0.45% |